These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29656178)

  • 21. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
    Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
    Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3.
    He L; Ye W; Chen Z; Wang C; Zhao H; Li S; Peng L; Han X; Zhou T; Li Z; Tang B; Jiang H
    Stem Cell Res; 2019 Oct; 40():101555. PubMed ID: 31491691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.
    Bavassano C; Eigentler A; Stanika R; Obermair GJ; Boesch S; Dechant G; Nat R
    Stem Cells Dev; 2017 Nov; 26(22):1612-1625. PubMed ID: 28946818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
    Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
    Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line (CSUXHi005-A) from human urine epithelial cells.
    He L; Han X; Zhao H; Li S; Chen Z; Wang C; Wang S; Peng L; Deng W; Li Z; Tang B; Jiang H
    Stem Cell Res; 2021 May; 53():102289. PubMed ID: 33761381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
    Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
    Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an Induced pluripotent stem cell (iPSC) line (IGIBi011-A) from a Spinocerebellar ataxia type 12 gait dominant patient.
    Zahra S; Kapoor H; Ahmad I; Kamai A; Srivastava AK; Faruq M
    Stem Cell Res; 2024 Apr; 76():103319. PubMed ID: 38340452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3.
    Wang Y; Shi C; Wang Z; Sun H; Yang Z; Zhang F; Liu Y; Liu H; Jiang C; Zhang S; Xu Y; Wen X
    Stem Cell Res; 2018 Apr; 28():71-74. PubMed ID: 29444500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.
    Hansen SK; Stummann TC; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Daechsel JC; Fog K; Hyttel P
    Stem Cell Res; 2016 Sep; 17(2):306-317. PubMed ID: 27596958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system.
    Uhm KO; Kim SJ; Jo EH; Go GY; Choi HY; Im YS; Ha HY; Kim JH; Koo SK
    Stem Cell Res; 2017 May; 21():13-15. PubMed ID: 28677527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines.
    Valetdinova KR; Maretina MA; Kuranova ML; Grigor'eva EV; Minina YM; Kizilova EA; Kiselev AV; Medvedev SP; Baranov VS; Zakian SM
    Stem Cell Res; 2019 Jan; 34():101376. PubMed ID: 30660867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs.
    Ishida Y; Kawakami H; Kitajima H; Nishiyama A; Sasai Y; Inoue H; Muguruma K
    Cell Rep; 2016 Nov; 17(6):1482-1490. PubMed ID: 27806289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of two induced pluripotent stem cell lines (LVPEIi007-B, LVPEIi008-B) from patients harboring homozygous mutation in ABCA4 (c.6088C>T) using non-integrative Sendai virus-based approach.
    Pidishetty D; Maddileti S; Mahato S; Agrawal T; Pulimamidi VK; Naik M; Kannabiran C; Jalali S; Mariappan I
    Stem Cell Res; 2024 Jun; 77():103418. PubMed ID: 38615588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.
    Cvetanovic M; Hu YS; Opal P
    Cerebellum; 2017 Apr; 16(2):340-347. PubMed ID: 27306906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of four iPSC lines from two siblings with a microdeletion at the CNTN6 gene and intellectual disability.
    Shnaider TA; Pristyazhnyuk IE; Menzorov AG; Matveeva NM; Nikitina TV; Khabarova AA; Skryabin NA; Kashevarova AA; Lopatkina ME; Nazarenko LP; Lebedev IN; Serov OL
    Stem Cell Res; 2019 Dec; 41():101591. PubMed ID: 31678775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of the human iPSC lines AKOSi011-A carrying the mutation p.Pro65Ser/p.Asp35T and AKOSi012-A, carrying the mutation p.Tyr231His, derived from FAHN patient fibroblasts.
    Efendic F; Krohn S; Murua Escobar H; Venkateswaran S; Bennett SAL; Hermann A; Frech MJ
    Stem Cell Res; 2023 Sep; 71():103178. PubMed ID: 37573804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation.
    Janz A; Chen R; Regensburger M; Ueda Y; Rost S; Klopocki E; Günther K; Edenhofer F; Duff HJ; Ergün S; Gerull B
    Stem Cell Res; 2020 Jul; 46():101856. PubMed ID: 32521499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of two induced pluripotent stem cell lines (HIMRi006-A and HIMRi007-A) from Pompe patients with infantile and late disease onset.
    Volke L; Daya NM; Döring K; Rohm M; Athamneh M; Zaehres H; Roos A; Güttsches AK; Mavrommatis L; Vorgerd M
    Stem Cell Res; 2024 Sep; 79():103459. PubMed ID: 38896971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6.
    Yang T; Qin J; Zhang Q; Sun H; Wang Z; Yang J; Liu H; Zhang C; Zhang S; Zhang J; Wang Y; Xu Y
    Stem Cell Res; 2020 Apr; 44():101777. PubMed ID: 32229428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.